Position in LNTH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,974,564
-$1,681,707 QoQ
Shares Held
105,136
-27.5% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Derivatives in LNTH
reported options exposure · as of Jun 30, 2025CallValue
$2,324,824
CallShares
28,400
PutValue
$900,460
PutShares
11,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $516,666,064 across 52 Drug Manufacturers - Specialty & Generic names. LNTH ranks #9 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,925 | $213,951,231 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,745,751 | $53,210,488 | |
| 3 | VTRS |
Viatris Inc
|
3,144,439 | $42,481,369 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,400,671 | $42,188,210 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
63,005 | $37,360,703 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
243,984 | $32,142,450 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
971,854 | $13,508,770 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
639,372 | $13,273,362 |
All Filings in LNTH
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,974,564 | 105,136 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,656,271 | 145,098 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,346,471 | 162,731 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $16,472,687 | 201,230 | Shares | Sole | 2026-02-27 | |
| 2025-06-30 | $2,324,824 | 28,400 | Call | Sole | 2026-02-27 | |
| 2025-06-30 | $900,460 | 11,000 | Put | Sole | 2026-02-27 | |
| 2025-03-31 | $14,419,521 | 147,741 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $14,342,137 | 160,319 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $13,830,256 | 126,016 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $3,179,644 | 39,602 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $7,445,833 | 119,631 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $11,008,162 | 177,551 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $1,612,000 | 26,000 | Put | Sole | 2026-03-24 | |
| 2023-09-30 | $3,674,865 | 52,891 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $6,936,154 | 82,652 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $8,019,547 | 97,136 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $4,126,333 | 80,972 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $2,270,110 | 32,278 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,495,315 | 22,646 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,132,039 | 56,627 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,601,082 | 90,034 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $1,386,231 | 53,981 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $970,329 | 35,106 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,788,945 | 83,713 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,000,498 | 74,166 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,424,195 | 112,407 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,268,467 | 88,704 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $763,609 | 59,844 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||